Integra Lifesciences Holdings Corp (NASDAQ: IART) on Tuesday, plunged -3.25% from the previous trading day, before settling in for the closing price of $21.55. Within the past 52 weeks, IART’s price has moved between $21.08 and $45.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.17%. The company achieved an average annual earnings per share of -20.97%. With a float of $64.98 million, this company’s outstanding shares have now reached $78.17 million.
Let’s determine the extent of company efficiency that accounts for 5329 employees. In terms of profitability, gross margin is 56.92%, operating margin of 7.77%, and the pretax margin is 1.73%.
Integra Lifesciences Holdings Corp (IART) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Integra Lifesciences Holdings Corp is 16.24%, while institutional ownership is 90.40%. The most recent insider transaction that took place on Aug 19 ’24, was worth 25,701. In this transaction SVP, Fin & Princ Acct Officer of this company sold 1,191 shares at a rate of $21.58, taking the stock ownership to the 36,088 shares. Before that another transaction happened on May 23 ’24, when Company’s Exec. Chairman of the Board bought 52,641 for $28.49, making the entire transaction worth $1,499,979. This insider now owns 487,922 shares in total.
Integra Lifesciences Holdings Corp (IART) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.76 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.78) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.30% during the next five years compared to 3.10% growth over the previous five years of trading.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Integra Lifesciences Holdings Corp (IART) is currently performing well based on its current performance indicators. A quick ratio of 2.10 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.03. Likewise, its price to free cash flow for the trailing twelve months is 27.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.30, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 2.51 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Looking closely at Integra Lifesciences Holdings Corp (NASDAQ: IART), its last 5-days average volume was 0.67 million, which is a drop from its year-to-date volume of 1.15 million. As of the previous 9 days, the stock’s Stochastic %D was 17.43%. Additionally, its Average True Range was 1.09.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 0.61%, which indicates a significant decrease from 2.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.06% in the past 14 days, which was lower than the 60.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.38, while its 200-day Moving Average is $34.44. However, in the short run, Integra Lifesciences Holdings Corp’s stock first resistance to watch stands at $21.29. Second resistance stands at $21.74. The third major resistance level sits at $22.00. If the price goes on to break the first support level at $20.58, it is likely to go to the next support level at $20.32. Now, if the price goes above the second support level, the third support stands at $19.87.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
Market capitalization of the company is 1.62 billion based on 78,800K outstanding shares. Right now, sales total 1,542 M and income totals 67,740 K. The company made 418,180 K in profit during its latest quarter, and -12,400 K in sales during its previous quarter.
